Cargando…

Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer

IMPORTANCE: Adjuvant chemotherapy remains the only recommended treatment for patients with triple-negative breast cancer (TNBC). However, the existing evidence is not enough to recommend adjuvant therapies to patients with T1 N0 M0 TNBC. OBJECTIVE: To evaluate the association of different adjuvant t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Zhen, Zheng, Yi, Yao, Jia, Liu, Yu, Ruan, Jian, Deng, Yujiao, Zhou, Linghui, Zhao, Peng, Yang, Si, Hu, Jingjing, We, Bajin, Wu, Ying, Zhang, Dai, Kang, Huafeng, Dai, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677762/ https://www.ncbi.nlm.nih.gov/pubmed/33211105 http://dx.doi.org/10.1001/jamanetworkopen.2020.21881

Ejemplares similares

Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair–Related Genes
por: Zhang, Dai, et al.
Publicado: (2020)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
por: Fu, Wen-Fen, et al.
Publicado: (2020)

Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035
por: Li, Yizhen, et al.
Publicado: (2022)

Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
por: Zhang, Dai, et al.
Publicado: (2021)

Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017
por: Zhai, Zhen, et al.
Publicado: (2021)

Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis
por: Wu, Chenghui, et al.
Publicado: (2023)

Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer
por: Lyu, Lijuan, et al.
Publicado: (2021)

Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer
por: Xu, Peng, et al.
Publicado: (2020)

Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
por: Li, Na, et al.
Publicado: (2019)

Global Burden of Thyroid Cancer From 1990 to 2017
por: Deng, YuJiao, et al.
Publicado: (2020)

Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database
por: Wu, Junzhao, et al.
Publicado: (2022)

Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population
por: Lim, SeungTaek, et al.
Publicado: (2015)

GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis
por: Zhou, Linghui, et al.
Publicado: (2019)

Effects of Antihypertensive Drugs Use on Risk and Prognosis of Colorectal Cancer: A Meta-Analysis of 37 Observational Studies
por: Deng, Yujiao, et al.
Publicado: (2022)

Association of 13 Occupational Carcinogens in Patients With Cancer, Individually and Collectively, 1990-2017
por: Li, Na, et al.
Publicado: (2021)

Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study
por: Deng, Yujiao, et al.
Publicado: (2020)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Association of vitamin C intake with breast cancer risk and mortality: a meta-analysis of observational studies
por: Zhang, Dai, et al.
Publicado: (2020)

Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer
por: Xia, Lin-Yu, et al.
Publicado: (2022)

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
por: Jeon, Chul-Hyo, et al.
Publicado: (2019)

Nomogram for Predicting Overall Survival and Assessing the Survival Benefit of Adjuvant Treatment in pT1-2N0M0 Triple-Negative Breast Cancer: A Surveillance, Epidemiology, and End Results-Based Study
por: Mao, Qixin, et al.
Publicado: (2022)

Global, regional, and national childhood cancer burden, 1990–2019: An analysis based on the Global Burden of Disease Study 2019
por: Wu, Ying, et al.
Publicado: (2022)

Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
por: Chen, Fengxia, et al.
Publicado: (2017)

The role of chemotherapy in patients with T1bN0M0 triple-negative breast cancer: a real-world competing risk analysis
por: Lan, Tian, et al.
Publicado: (2021)

DCB combined with provisional DES implantation in the treatment of De Novo Medina 0,1,0 or 0,0,1 left main coronary bifurcation lesions: A proof-of-concept study
por: Erdoğan, Emrah, et al.
Publicado: (2022)

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
por: Li, Xiao-hui, et al.
Publicado: (2022)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
por: Sasada, Shinsuke, et al.
Publicado: (2023)

Dietary Risk-Related Colorectal Cancer Burden: Estimates From 1990 to 2019
por: Deng, Yujiao, et al.
Publicado: (2021)

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial
por: Yu, Ke-Da, et al.
Publicado: (2020)

Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients
por: Deng, Yujiao, et al.
Publicado: (2021)

Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
por: Huang, Ze-Ning, et al.
Publicado: (2019)

Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
por: Peng, Kunwei, et al.
Publicado: (2021)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022)

Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study
por: Lin, Shuai, et al.
Publicado: (2022)

Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study
por: Zhou, Linghui, et al.
Publicado: (2019)

Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down‐regulation of JAK2/STAT3 pathway
por: Liu, Kang, et al.
Publicado: (2019)

Efficient ancestry and mutation simulation with msprime 1.0
por: Baumdicker, Franz, et al.
Publicado: (2021)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies
por: Song, Dingli, et al.
Publicado: (2019)

Comparison of T2N0M0 and T3aN0M0 in Predicting the Prognosis of Patients With Renal Cell Carcinoma
por: He, Xiaobo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ma86us4i6q2oonbcggctcogk9k